Neugenesis Corporation And PATH Sign Collaboration Agreement to Develop an Influenza Vaccine Production System

Published: Jul 07, 2009

BURLINGAME, Calif.--(BUSINESS WIRE)--Neugenesis Corporation today announced a collaboration with PATH to develop an influenza vaccine production system. Under the agreement, Neugenesis will conduct proof of concept work to demonstrate the utility of the NeuBIOS™ protein production platform for making seasonal and pandemic influenza vaccine.

Back to news